NEW YORK (GenomeWeb) – OneOme announced today that it has signed an agreement to offer its RightMed pharmacogenomic test in Canada through medication management firm ProZed Pharmacy Solutions.
Under the terms of the deal, OneOme's PCR-based RightMed test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be exclusively available to ProZed customers at Northern Shores Pharmacy in North Bay, Ontario.
OneOme said that the agreement marks its first step in a Canada-wide launch of the test. Additional terms of the deal were not disclosed.
"ProZed Pharmacy Solutions is the first company to offer OneOme's RightMed PGx test in a retail pharmacy setting in Canada and we are glad to be expanding our efforts to make prescriptions personal," OneOme CEO Paul Owen said in a statement. "Through this partnership, we hope to not only improve health and lower costs, but also to determine how communities globally can best implement pharmacogenomic testing and support."
Earlier this month, OneOme partnered with Total Quality Medicine to offer RightMed in Mexico.